'Environmental exposure' presentation slideshows

Environmental effects & skin diseases

Environmental effects & skin diseases. By Dr. Shereen Gheida Lecturer of Dermatology & Venereology. Environmental effects& skin disease.

884 views • 61 slides

K-12 Risk Communication

K-12 Risk Communication. Larry Johnson Partnership for Environmental Education and Rural Health (PEER) Texas A & M University. K-12 Risk Communication. Inform of danger (potential, likely, or real risk).

460 views • 32 slides

Xenia Gonda Semmelweis University, Department of Psychiatry and Psychotherapy

Not all stressors are created equal : the divergent genetic background of distinct stressors in depression. Xenia Gonda Semmelweis University, Department of Psychiatry and Psychotherapy MTA-SE Neurochemistry and Neuropsychopharmacology Research Group

315 views • 29 slides

Medical aspects of asbestos exposure

Medical aspects of asbestos exposure. Sjaak Burgers respiratory physician Netherlands Cancer Institute, Amsterdam. s.burgers@nki.nl. Medical consequences. mesothelioma asbestosis lung cancer benign pleural plaques. Today. Medical introduction Asbestos mesothelioma lung cancer

349 views • 24 slides

Variable effects of environment due to genetics.

275 views • 21 slides

A 53-year-old male with clumsiness

A 53-year-old male with clumsiness. Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6. History. The patient was a 53 year male with a 10 year history of clumsiness

215 views • 21 slides

Session 6 (B) Durability Assessment of Structures

Session 6 (B) Durability Assessment of Structures. Dr. Paul J. Tikalsky, P.E., FACI The Pennsylvania State University USA. Durability Based Design. 6 steps Defining environmental exposure Defining the desired life Defining required performance Modeling performance vs. exposure vs. life

285 views • 19 slides

Supercourse

Supercourse. Environmental Exposure Assessment And Biomarkers Wael Al-Delaimy, MD, PhD. Environmental and O ccupational Epidemiology: study the distribution of human health and disease in relationship to exposure to agents in the general and occupational environment.

338 views • 18 slides

Use of Drager Pump & Tubes

Use of Drager Pump & Tubes. Preparation . Pump Leak Test. Insert unopened tube into the socket Squeeze pump completely and release Pump is adequately leak-proof if the end-of-stroke volume indicator has not appeared after 15 minutes Remove tube from socket

798 views • 14 slides

CZ.1.07/2.4.00/17.0080

217 views • 14 slides

Use of Drager Pump & Tubes

Use of Drager Pump & Tubes. Preparation . Pump Leak Test. Insert unopened tube into the socket Squeeze pump completely and release Pump is adequately leak-proof if the end-of-stroke volume indicator has not appeared after 15 minutes Remove tube from socket

505 views • 13 slides

Bioaerosols from Compost Facilities

Bioaerosols from Compost Facilities. Ginny Black Minnesota Pollution Control Agency ginny.black@state.mn.us. Compost Process. Harness the activity of naturally occurring micro-organisms Commonly present in soil Cause the decay of leaves and other organic materials

243 views • 13 slides

Genetic Diseases

Genetic Diseases. By: Mr. Hunter. What is a genetic disorders?. A genetic disorder is a disease caused by a different form of a gene called a variation or an alteration of a gene called a mutation. Mutations. Mutations can occur randomly or because of an environmental exposure.

374 views • 9 slides

Problem - Approach

Rapid Assessment and Characterization of Environmental Risks ( RACER) - A New Software Tool - Gary M. Marsh, Ph.D. Michael Cunningham, M.S. D epartment of Biostatistics Graduate School of Public Health Pittsburgh Environmental Summit - April 18, 2007. Problem - Approach.

187 views • 9 slides

Dr. Tatyana N. Chernysheva, M.D.; Tatyana P. Apukhtina, M.D. ;

236 views • 8 slides

U.S. Food and Drug Administration

206 views • 7 slides

Public Disclosure and Environmental Assessment

Public Disclosure and Environmental Assessment. Public Disclosure. Questions: (a) should we disclose to the public that we are considering an import tolerance for a new animal drug? If so, (b) when, (c) how, and (d) in how much detail?. Public Disclosure.

168 views • 6 slides

Justifying Gaslift Automation

179 views • 3 slides